Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Germany / NCT03511586
Recruiting Observational

Total Shoulder Arthroplasty Multi-Center Registry

NCT03511586 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2015-07-28
Last updated
2026-08-20

Condition(s) studied

Shoulder Arthroplasty

Study summary

The objective of the study is a multi-center prospective registry to collect clinical outcomes of anatomic and reverse total shoulder arthroplasty.

Eligibility

Sex
ALL
Min age
18 Years
Max age
100 Years
Healthy volunteers
No
Inclusion Criteria: 1. Patient voluntarily consents to participate in the study and has the mental and physical ability to participate in the study, fill out subjective questionnaires, return for follow-up visits, and comply with prescribed post-operative physical therapy. 2. Patient is between the ages of 18 and 100 years. 3. The patient has a planned primary or revision implantation of an anatomic (hemi-arthroplasty or total arthroplasty) or a reverse shoulder prosthesis system manufactured by Arthrex. 4. Patient has a standard of care preoperative CT taken within 6 months that has been submitted for Arthrex VIP (Virtual Implant Positioning) planning (not required for acute humeral fractures). Exclusion Criteria 1\. Patient has known intentions, obligations, or co-morbidity that would inhibit them from participating in the study.

Primary outcome measure(s)

Trial sites (27)

FacilityCityRegionStatus
University of Arizona/Banner Health Phoenix Arizona Recruiting
Banner Medical Group Phoenix Arizona Recruiting
Orthopedic Surgery (Mayo Scottsdale) Phoenix Arizona Recruiting
HCA Research Institute LLC. Denver Colorado Recruiting
University of Connecticut Health Center Farmington Connecticut Terminated
University of Florida Gainesville Florida Recruiting
Andrews Research & Education Foundation Gulf Breeze Florida Recruiting
Advent Health Orlando Orlando Florida Recruiting
NorthShore University Health System Evanston Illinois Withdrawn
The Trustees of Indiana University Indianapolis Indiana Recruiting
The University of Michigan Ann Arbor Michigan Recruiting
— Grand Rapids Michigan Terminated
— Columbia Missouri Terminated
The Rothman Institute New York New York Terminated
University of North Carolina Chapel Hill North Carolina Recruiting
Wake Forest University Health Sciences Winston-Salem North Carolina Not Yet Recruiting
Cleveland Shoulder Institute Beachwood Ohio Active Not Recruiting
Southern Oregon Orthopedics Medford Oregon Recruiting
Rothman Orthopaedic Institute Philadelphia Pennsylvania Active Not Recruiting
The Hawkins Foundation Greenville South Carolina Recruiting
Campbell Foundation Germantown Tennessee Recruiting
University of Virginia Charlottesville Virginia Recruiting
Jordan Young Institute Virginia Beach Virginia Recruiting
Orthopädische Chirurgie München (OCM) München Germany Recruiting
Schulthess Klinik Zurich Switzerland Recruiting
Universitätsklinik Balgrist Zurich Switzerland Not Yet Recruiting
Wrightington Hospital Wigan United Kingdom Recruiting

More Arthrex, Inc. trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03511586 on ClinicalTrials.gov ↗ ← All trials in Germany